ConductScience.org, home

Paper28869

Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.

Richards DA and 2 others. Clin Pharmacol Ther, 1978. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol. Papers, record 28869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28869

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.86
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richards DAD A
2Prichard BNB N
3Dobbs RJR J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
HemodynamicsMajor topic
IsoproterenolMajor topic
Adult
Blood Pressure
Cardiac Output
Heart Rate
Humans
Labetalol
Male
Myocardial Contraction
Phentolamine
Propranolol
Stroke Volume
Time Factors

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
7295463The effect of labetalol and propranolol on the pressor response to sexual arousal in women.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7295463PubMed
7126388Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.Br Heart J1982https://conductscience.org/library/papers/7126388PubMed
7093095Renal haemodynamics after chronic treatment with labetalol and propranolol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093095PubMed
6874287Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.Ir J Med Sci1983https://conductscience.org/library/papers/6874287PubMed
6807469Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6807469PubMed
6151889Pharmacology of combined alpha-beta-blockade. I.Drugs1984https://conductscience.org/library/papers/6151889PubMed
2908732Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/2908732PubMed
444356Circulatory effects of noradrenaline and adrenaline before and after labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/444356PubMed
43165Clinical pharmacology of labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/43165PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28869

GET https://conductscience.org/api/papers/v1/28869/authors